Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapy
Research on chemotherapy reported by scientists at University of Nebraska
March 2nd, 2007
New investigation results, "Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis," are detailed in a study published in Antimicrobial Agents and Chemotherapy. According to recent research from the United States, "The most common mechanism by which Staphylococcus aureus gains resistance to vancomycin is by adapting its physiology and metabolism to permit growth in the presence of vancomycin. Several studies have examined the adaptive changes occurring during the transition to vancomycin-intermediate resistance, leading to a model of vancomycin resistance in which decreased...
Source: Drug Week (2007-03-02)
|
|
Advertisement |
|
|
|
